Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for ITGR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 -23.58M
March 31, 2026 3.83M
December 31, 2025 -61.72M
September 30, 2025 -10.71M
June 30, 2025 -35.59M
March 31, 2025 151.58M
December 31, 2024 -82.30M
September 30, 2024 -43.14M
June 30, 2024 -24.53M
March 31, 2024 163.29M
December 31, 2023 17.52M
September 30, 2023 -43.13M
June 30, 2023 -25.52M
March 31, 2023 33.12M
December 31, 2022 -13.94M
September 30, 2022 -9.191M
June 30, 2022 116.63M
March 31, 2022 -1.028M
December 31, 2021 194.05M
September 30, 2021 -43.02M
June 30, 2021 -19.48M
March 31, 2021 -49.56M
December 31, 2020 -110.28M
September 30, 2020 -129.25M
June 30, 2020 135.78M
Date Value
March 31, 2020 15.16M
December 31, 2019 -15.49M
September 30, 2019 -36.16M
June 30, 2019 -50.11M
March 31, 2019 -16.16M
December 31, 2018 -0.193M
September 30, 2018 -618.37M
June 30, 2018 -23.31M
March 31, 2018 -51.21M
December 31, 2017 -20.35M
September 30, 2017 -29.41M
June 30, 2017 -38.41M
March 31, 2017 -23.49M
December 31, 2016 -13.28M
September 30, 2016 -12.14M
June 30, 2016 -6.64M
March 31, 2016 -33.27M
December 31, 2015 479.62M
September 30, 2015 -1.315M
June 30, 2015 -1.367M
March 31, 2015 0.852M
December 31, 2014 0.477M
September 30, 2014 -2.078M
June 30, 2014 -0.113M
March 31, 2014 -0.663M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. -134.50M
Integra LifeSciences Holdings Corp. -0.818M
Abbott Laboratories -3.518B
AngioDynamics, Inc. -0.108M
Alphatec Holdings, Inc. -19.53M